These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23388401)

  • 1. Identified mortality risk factors associated with presentation, initial hospitalisation, and interstage period for the Norwood operation in a multi-centre registry: a report from the national pediatric cardiology-quality improvement collaborative.
    Cross RR; Harahsheh AS; McCarter R; Martin GR;
    Cardiol Young; 2014 Apr; 24(2):253-62. PubMed ID: 23388401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoplastic left heart syndrome and aortic atresia-mitral stenosis variant: role of myocardial protection strategy and impact of ventriculo-coronary connections after stage I palliation.
    Polimenakos AC; Sathanandam SK; Husayni TS; El Zein CF; Roberson DA; Ilbawi MN
    Pediatr Cardiol; 2011 Oct; 32(7):929-39. PubMed ID: 21644013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of mitral stenosis and aortic atresia on survival in hypoplastic left heart syndrome.
    Glatz JA; Fedderly RT; Ghanayem NS; Tweddell JS
    Ann Thorac Surg; 2008 Jun; 85(6):2057-62. PubMed ID: 18498820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitral Stenosis and Aortic Atresia--A Risk Factor for Mortality After the Modified Norwood Operation in Hypoplastic Left Heart Syndrome.
    Siehr SL; Maeda K; Connolly AA; Tacy TA; Reddy VM; Hanley FL; Perry SB; Wright GE
    Ann Thorac Surg; 2016 Jan; 101(1):162-7. PubMed ID: 26602002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive Atrial Septum Defect Becomes a Risk Factor for Norwood Palliation of Hypoplastic Left Heart Syndrome Only When It Is Combined with Mitral or Aortic Atresia.
    Sata S; Sinzobahamvya N; Arenz C; Zartner P; Asfour B; Hraska V
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):354-9. PubMed ID: 24788706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of antithrombotics use in patients with hypoplastic left heart syndrome and its variants following first- and second-stage palliation surgery: a national report using the National Pediatric Cardiology Quality Improvement Collaborative registry.
    Ramachandran P; King E; Nebbia A; Beekman RH; Anderson JB
    Cardiol Young; 2017 May; 27(4):731-738. PubMed ID: 27981915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining variation in interstage mortality rates across the National Pediatric Cardiology Quality Improvement Collaborative: do lower-mortality centres have lower-risk patients?
    Bates KE; Yu S; Lowery R; Pasquali SK; Brown DW; Manning PB; Uzark K
    Cardiol Young; 2018 Aug; 28(8):1031-1036. PubMed ID: 29925455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstage attrition between bidirectional Glenn and Fontan palliation in children with hypoplastic left heart syndrome.
    Carlo WF; Carberry KE; Heinle JS; Morales DL; McKenzie ED; Fraser CD; Nelson DP
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):511-6. PubMed ID: 21704339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Unanticipated Readmissions During the Interstage: A Report From the National Pediatric Cardiology Quality Improvement Collaborative.
    Hanke SP; Joy B; Riddle E; Ravishankar C; Peterson LE; King E; Mangeot C; Brown DW; Schoettker P; Anderson JB; Bates KE
    Semin Thorac Cardiovasc Surg; 2016 Winter; 28(4):803-814. PubMed ID: 28417868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial.
    Ghanayem NS; Allen KR; Tabbutt S; Atz AM; Clabby ML; Cooper DS; Eghtesady P; Frommelt PC; Gruber PJ; Hill KD; Kaltman JR; Laussen PC; Lewis AB; Lurito KJ; Minich LL; Ohye RG; Schonbeck JV; Schwartz SM; Singh RK; Goldberg CS;
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):896-906. PubMed ID: 22795436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database.
    Baker-Smith CM; Goldberg SW; Rosenthal GL
    Pediatr Cardiol; 2015 Dec; 36(8):1630-41. PubMed ID: 26036350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arch intervention following stage 1 palliation in hypoplastic left heart syndrome is associated with slower feed advancement: a report from the National Pediatric Quality Cardiology Improvement Collaborative.
    Chaves AH; Baker-Smith CM; Rosenthal GL
    Cardiol Young; 2020 Mar; 30(3):396-401. PubMed ID: 32008590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course and interstage monitoring after the Norwood and hybrid procedures for hypoplastic left heart syndrome.
    Knirsch W; Bertholdt S; Stoffel G; Stiasny B; Weber R; Dave H; Prêtre R; von Rhein M; Kretschmar O
    Pediatr Cardiol; 2014 Jun; 35(5):851-6. PubMed ID: 24442219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying best practices in interstage care: using a positive deviance approach within the National Pediatric Cardiology Quality Improvement Collaborative.
    Bates KE; Yu S; Mangeot C; Shea JA; Brown DW; Uzark K
    Cardiol Young; 2019 Mar; 29(3):398-407. PubMed ID: 30806343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and resource use for infants with hypoplastic left heart syndrome during bidirectional Glenn: summary from the Joint Council for Congenital Heart Disease National Pediatric Cardiology Quality Improvement Collaborative registry.
    Menon SC; McCandless RT; Mack GK; Lambert LM; McFadden M; Williams RV; Minich LL
    Pediatr Cardiol; 2013 Jan; 34(1):143-8. PubMed ID: 22673966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a learning network to improve variation in interstage weight gain after the Norwood operation.
    Anderson JB; Beekman RH; Kugler JD; Rosenthal GL; Jenkins KJ; Klitzner TS; Martin GR; Neish SR; Darbie L; King E; Lannon C;
    Congenit Heart Dis; 2014; 9(6):512-20. PubMed ID: 25358553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice trends over time in the care of infants with hypoplastic left heart syndrome: A report from the National Pediatric Cardiology Quality Improvement Collaborative.
    Carlo WF; Cnota JF; Dabal RJ; Anderson JB
    Congenit Heart Dis; 2017 May; 12(3):315-321. PubMed ID: 28121380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of interstage care, resource utilization, and interstage mortality: a report from the NPC-QIC registry.
    Schidlow DN; Gauvreau K; Patel M; Uzark K; Brown DW
    Pediatr Cardiol; 2015 Jan; 36(1):126-31. PubMed ID: 25107545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of preoperative risk factors on outcomes after Norwood palliation for hypoplastic left heart syndrome.
    Shamszad P; Gospin TA; Hong BJ; McKenzie ED; Petit CJ
    J Thorac Cardiovasc Surg; 2014 Mar; 147(3):897-901. PubMed ID: 23849462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical palliation strategy does not affect interstage ventricular dysfunction or atrioventricular valve regurgitation in children with hypoplastic left heart syndrome and variants.
    Chetan D; Kotani Y; Jacques F; Poynter JA; Benson LN; Lee KJ; Chaturvedi RR; Friedberg MK; Van Arsdell GS; Caldarone CA; Honjo O
    Circulation; 2013 Sep; 128(11 Suppl 1):S205-12. PubMed ID: 24030408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.